REPROCELL
Joseph Rogers is an experienced professional in the fields of bioengineering and regenerative medicine. Currently serving as the Commercial Manager for Stem Cells at REPROCELL since February 2023, Joseph previously held the position of Quality Assurance Associate at Organicell Regenerative Medicine from January 2022 to January 2023. Joseph's background also includes roles as a Research Associate and Clinic Assistant at the University of Miami's Miller School of Medicine between June 2017 and January 2022, as well as a New Product Development Engineer at InNeuroCo, Inc. from May to August 2021. Joseph holds a Master of Science in Bioengineering and Biomedical Engineering from the University of Miami, obtained in 2020, and a Bachelor of Science in Biology from the same institution, completed in 2015.
This person is not in the org chart
This person is not in any offices
REPROCELL
ReproCELL Incorporated is primarily engaged in the development of stem cell technologies. The Company operates its business in two segments. The IPS Cell segment deals with regenerative medicine focused on Human ES (embryonic stem) cells and human iPS (induced pluripotent stem) cells. This segment manufactures research reagents used in human ES/ iPS cell research, such as culture fluid, peeling liquid, frozen preservation solution, coating agents and antibody. The Clinical Testing segment clinical testing services that is required by hematopoietic stem cell transplantation and organ transplantation. On February 10, 2014, it established a Kanagawa-based wholly owned subsidiary. On June 30, 2014, it acquired 85.2% interests in Reinnervate Limited, a UK-based company. On July 1, 2014, it fully acquired Reinnervate Limited. In July, 2014, it acquired BioServe Biotechnologies, Ltd. On September 2, 2014, it completed the acquisition of BioServe Biotechnologies, Ltd.